How to appeal a CareFirst BCBS gerd & severe reflux denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

CareFirst BCBS-specific note: BCBS licensee for Maryland, DC, and northern Virginia (~3.5M members). Operates as non-profit. Appeals jurisdiction depends on policy issue location — MIA (MD), DISB (DC), or SCC Bureau of Insurance (VA). CVS Caremark is the PBM.

What CareFirst BCBS's policy requires for gerd & severe reflux

Cited policy: BCBS Anti-Reflux Surgery — Nissen / Toupet Fundoplication

Objective GERD evidence (EGD erosive esophagitis >=LA-B OR pH-impedance abnormal off PPI). Failure / intolerance of medical therapy OR patient preference for surgical management with adequate response. Manometry to rule out achalasia / major motility disorder (avoid 360° Nissen in IEM — use Toupet instead).

How CareFirst BCBS denies gerd & severe reflux — and how to counter it

Where CareFirst BCBS pushes back: 1) More PPI trial required; 2) Patient is PPI-responder; 3) Manometry not done.

Counter-arguments that hold up: LOTUS JAMA 2011 + REFLUX UK BMJ 2008 — long-term surgical superiority for objective GERD with hiatal hernia. Spechler NEJM 1992 — surgery effective even in PPI-responders. Anatomic hiatal hernia is mechanical, not pharmacologic, problem. Submit DeMeester >14.72, EGD with hiatal hernia, manometry showing normal/IEM motility (Toupet for IEM).

What CareFirst BCBS typically denies for gerd & severe reflux

Across CareFirst BCBS's commercial and Medicare books, denials cluster around a small number of patterns. For gerd & severe reflux, expect:

• DC/MD/VA cross-jurisdiction issues
• Step therapy on specialty drugs via CVS Caremark
• Behavioral health network adequacy
• BlueChoice HMO referral denials

Treatments most often denied in this category

These are the gerd & severe reflux treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Generic PPI
• Branded PPI
• Voquezna (vonoprazan)
• H2 blocker
• Prokinetic
• Sucralfate

How to submit the appeal to CareFirst BCBS

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document CareFirst BCBS cited in the denial.
3. File the appeal through CareFirst BCBS's portal (members: https://member.carefirst.com ; providers: https://provider.carefirst.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MD, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See CareFirst BCBS's prior-authorization criteria by drug: CareFirst BCBS PA criteria on ApprovalHelp.